Stryker Share Price (NYSE: SYK)

$381.86

▲

3.34

(0.88%)

Last updated on August 16, 2025 at 1:29 AM IST

$₹

Check the interactive Stryker Stock chart to analyse performance

Stryker stock performance

as on August 16, 2025 at 1:29 AM IST

Today's Low:$379.22
Today's High:$382.86
$381.86
0.69%
Downside
Day's Volatility :0.95%
Upside
0.26%
52 Weeks Low:$329.16
52 Weeks High:$406.19
$381.86
13.8%
Downside
52 Weeks Volatility :18.96%
Upside
5.99%

Stryker Stock Returns

Period	Stryker Corporation	Sector (Health Care)	S&P500
3 Months	-3.25%	2.3%	8.2%
6 Months	-0.97%	-5.9%	5.5%
1 Year	13.01%	-10.9%	16.1%
3 Years	72.45%	1.7%	49.8%

Stryker Corporation Key Stats

Check Stryker key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$378.52
Open	$380.49
Today's High	$382.86
Today's Low	$379.22
Market Capitalization	$144.7B
Today's Volume	$1.1M
52 Week High	$406.19
52 Week Low	$329.1608
Revenue TTM	$23.8B
EBITDA	$6.4B
Earnings Per Share (EPS)	$7.53
PE Ratio	50.27
Dividend Yield	0.88%
Profit Margin	12.25%
Quarterly Earnings Growth YOY	0.07%
Return On Equity TTM	14.25%

Stock Returns calculator for Stryker Stock including INR - Dollar returns

The Stryker stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Stryker investment value today

Current value as on today

₹1,17,223

Returns

₹17,223

(+17.22%)

Returns from Stryker Stock

₹13,013 (+13.01%)

Dollar Returns*

₹4,210 (+4.21%)

Indian investors sentiment towards Stryker Stock

63%

Period: Jul 16, 2025 to Aug 15, 2025. Change in 30 Days versus previous period

Search interest for Stryker Stock from India on INDmoney has increased by 63% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Stryker Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	2780	12.76	0.25%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	541	0.00	1.12%

Global Institutional Holdings in Stryker Corporation

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
8.65%
BlackRock Inc
7.11%
Greenleaf Trust
4.37%
State Street Corp
3.87%
JPMorgan Chase & Co
3.30%
T. Rowe Price Associates, Inc.
3.17%

Analyst Recommendation on Stryker Stock

Rating

Trend

Buy

67%Buy

32%Hold

0%Sell

Based on 34 Wall street analysts offering stock ratings for Stryker(by analysts ranked 0 to 5 stars)

Stryker Share Price Target

What analysts predicted

Upside of 13.2%

Target:

$432.27

Current:

$381.86

Stryker share price target is $432.27, a slight Upside of 13.2% compared to current price of $381.86 as per analysts' prediction.

Stryker Stock Insights

Price Movement
In the last 3 years, SYK stock has moved up by 70.4%
Increasing Revenue
Stryker Corporation has seen consistent revenue growth over the past two quarters. The company's revenue increased from $5.86 billion to $6.02 billion, marking an average rise of 2.6% per quarter.
Increasing Net Profit
Stryker Corporation has shown strong profit performance over the last three quarters, with net profit increasing from $546.0 million to $884.0 million. This reflects an average profit growth of 21.3% each quarter.
SYK vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 31.9% return, outperforming this stock by 18.9%
SYK vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 143.7% return, outperforming this stock by 73.3%
Price to Sales
Stryker Corporation (SYK) has a Price-to-Sales Ratio of 6.1, meaning that investors are willing to pay $6.1 for every $1 of sales the company generates. In comparison, Boston Scientific Corp. has a higher Price-to-Sales Ratio of 8.2, indicating that investors are willing to pay more for each dollar of sales from Boston Scientific.

Stryker Corporation Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$14.9B	↑ 9.43%
Net Income	$2.1B	↓ 41.37%
Net Profit Margin	13.99%	↓ 12.13%

	FY20	Y/Y Change
Revenue	$14.4B	↓ 3.58%
Net Income	$1.6B	↓ 23.24%
Net Profit Margin	11.14%	↓ 2.85%

	FY21	Y/Y Change
Revenue	$17.1B	↑ 19.21%
Net Income	$2.0B	↑ 24.7%
Net Profit Margin	11.66%	↑ 0.52%

	FY22	Y/Y Change
Revenue	$18.4B	↑ 7.84%
Net Income	$2.4B	↑ 18.25%
Net Profit Margin	12.78%	↑ 1.12%

	FY23	Y/Y Change
Revenue	$20.5B	↑ 11.11%
Net Income	$3.2B	↑ 34.22%
Net Profit Margin	15.44%	↑ 2.66%

	FY24	Y/Y Change
Revenue	$22.6B	↑ 10.23%
Net Income	$3.0B	↓ 5.43%
Net Profit Margin	13.25%	↓ 2.19%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$5.2B	↓ 9.84%
Net Income	$788.0M	↓ 31.06%
Net Profit Margin	15.03%	↓ 4.63%

	Q2 FY24	Q/Q Change
Revenue	$5.4B	↑ 3.41%
Net Income	$825.0M	↑ 4.7%
Net Profit Margin	15.22%	↑ 0.19%

	Q3 FY24	Q/Q Change
Revenue	$5.5B	↑ 1.33%
Net Income	$834.0M	↑ 1.09%
Net Profit Margin	15.18%	↓ 0.04%

	Q4 FY24	Q/Q Change
Revenue	$6.4B	↑ 17.15%
Net Income	$546.0M	↓ 34.53%
Net Profit Margin	8.48%	↓ 6.7%

	Q1 FY25	Q/Q Change
Revenue	$5.9B	↓ 8.86%
Net Income	$654.0M	↑ 19.78%
Net Profit Margin	11.15%	↑ 2.67%

	Q2 FY25	Q/Q Change
Revenue	$6.0B	↑ 2.66%
Net Income	$884.0M	↑ 35.17%
Net Profit Margin	14.68%	↑ 3.53%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$9.4B	↑ 9.09%

	FY20	Y/Y Change
Profit	$8.8B	↓ 6.7%

	FY21	Y/Y Change
Profit	$10.7B	↑ 22.35%

	FY22	Y/Y Change
Profit	$11.0B	↑ 3.09%

	FY23	Y/Y Change
Profit	$12.5B	↑ 13.17%

	FY24	Y/Y Change
Profit	$14.0B	↑ 11.89%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$3.2B	↓ 10.13%

	Q2 FY24	Q/Q Change
Profit	$3.3B	↑ 4.07%

	Q3 FY24	Q/Q Change
Profit	$3.4B	↑ 2.08%

	Q4 FY24	Q/Q Change
Profit	$4.0B	↑ 17.57%

	Q1 FY25	Q/Q Change
Profit	$3.7B	↓ 7.75%

	Q2 FY25	Q/Q Change
Profit	$3.8B	↑ 1.9%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$2.2B	↓ 16.05%
Investing Cash Flow	$-1.5B	↓ 49.07%
Financing Cash Flow	$3.0M	↓ 99.77%

	FY20	Y/Y Change
Operating Cash Flow	$3.3B	↑ 49.57%
Investing Cash Flow	$-4.7B	↑ 223.09%
Financing Cash Flow	$-11.0M	↓ 466.67%

	FY21	Y/Y Change
Operating Cash Flow	$3.3B	↓ 0.43%
Investing Cash Flow	$-859.0M	↓ 81.73%
Financing Cash Flow	$-2.4B	↑ 21400.0%

	FY22	Y/Y Change
Operating Cash Flow	$2.6B	↓ 19.58%
Investing Cash Flow	$-2.9B	↑ 240.4%
Financing Cash Flow	$-749.0M	↓ 68.33%

	FY23	Y/Y Change
Operating Cash Flow	$3.7B	↑ 41.43%
Investing Cash Flow	$-962.0M	↓ 67.1%
Financing Cash Flow	$-1.6B	↑ 112.82%

	FY24	Y/Y Change
Operating Cash Flow	$4.2B	↑ 14.31%
Investing Cash Flow	$-3.0B	↑ 211.85%
Financing Cash Flow	$-525.0M	↓ 67.06%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$204.0M	↓ 86.65%
Investing Cash Flow	$-408.0M	↑ 168.42%
Financing Cash Flow	$-418.0M	↑ 46.15%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$633.0M	↑ 210.29%
Investing Cash Flow	$-117.0M	↓ 71.32%
Financing Cash Flow	$-966.0M	↑ 131.1%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$1.5B	↑ 132.86%
Investing Cash Flow	$-2.2B	↑ 1756.41%
Financing Cash Flow	$2.7B	↓ 374.64%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$1.9B	↑ 31.0%
Investing Cash Flow	$-303.0M	↓ 86.05%
Financing Cash Flow	$-1.8B	↓ 167.62%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$250.0M	↓ 87.05%
Investing Cash Flow	$-4.1B	↑ 1265.02%
Financing Cash Flow	$2.5B	↓ 241.25%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$1.4B	↑ 444.4%
Investing Cash Flow	$-4.2B	↑ 2.51%
Financing Cash Flow	$1.5B	↓ 39.03%

Stryker Technicals Summary

Sell

Neutral

Buy

Stryker is currently in a neutral trading position according to technical analysis indicators.

Stryker Corporation Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Stryker Corporation	-1.81%	-0.97%	13.01%	72.45%	102.01%
Medtronic Plc	3.88%	8.05%	9.93%	-2.01%	-8.7%
Edwards Lifesciences Corp.	2.7%	3.4%	13.52%	-22.17%	-0.25%
Boston Scientific Corp.	-1.38%	-2.03%	31.9%	143.25%	162.29%
Abbott Laboratories	9.33%	1.21%	18.69%	19.18%	30.82%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Stryker Corporation	50.27	50.27	2.15	13.49	0.14	0.08	0.01	55.43
Medtronic Plc	25.51	25.51	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	32.74	32.74	4.67	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	61.99	61.99	1.81	2.98	0.12	0.05	NA	15.14
Abbott Laboratories	16.22	16.22	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Stryker Corporation	Buy	$144.7B	102.01%	50.27	12.25%
Medtronic Plc	Buy	$118.0B	-8.7%	25.51	13.9%
Edwards Lifesciences Corp.	Buy	$45.9B	-0.25%	32.74	72.96%
Boston Scientific Corp.	Buy	$154.3B	162.29%	61.99	13.55%
Abbott Laboratories	Buy	$225.0B	30.82%	16.22	32.43%

Stryker Dividend announcements

Stryker Dividends September, 2025
In the quarter ending September,2025. Stryker has declared dividend of $0.84

About Stryker Corporation

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Organization	Stryker
Employees	53000
CEO	Mr. Kevin A. Lobo
Industry	Health Technology

Key Management of Stryker Corporation

Name	Title
Mr. Kevin A. Lobo	Chairman, CEO & President
Mr. Viju S. Menon	Group President of Global Quality & Operations
Mr. Glenn S. Boehnlein CPA	Advisor
Mr. J. Andrew Pierce	Group President of MedSurg & Neurotechnology
Mr. Spencer S. Stiles	Group President of Orthopaedics & Spine
Mr. Preston Wells	VP & CFO
Mr. William E. Berry Jr.	VP & Chief Accounting Officer
Mr. Robert C. Cohen	CTO and VP of Global R&D - Joint Replacement
Mr. Alan Douville	VP, Chief Information Officer & Chief Information Security Officer
Mr. Jason Beach	Vice President of Finance & Investor Relations

Important FAQs about investing in SYK Stock from India :

What is Stryker share price today?

Stryker share price today is $381.86 as on August 16, 2025 at 1:29 AM IST at the close of the market. Stryker share today touched a day high of $382.86 and a low of $379.22.

What is the 52 week high and 52 week low for Stryker share?

Stryker share touched a 52 week high of $406.19 and a 52 week low of $329.16. Stryker stock price today, August 16, 2025 at 1:29 AM IST is trending at $381.86, lower by 5.99% versus the 52 week high.

How to invest in Stryker Stock (SYK) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Stryker on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Stryker Shares that will get you 0.0039 shares as per Stryker share price of $381.86 per share as on August 16, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Stryker Stock (SYK) from India?

Indian investors can start investing in Stryker (SYK) shares with as little as ₹87.492 or $1 (as of August 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Stryker stock (as per the Rupee-Dollar exchange rate as on August 16, 2025). Based on Stryker share’s latest price of $381.86 as on August 16, 2025 at 1:29 AM IST, you will get 0.0262 shares of Stryker. Learn more about fractional shares .

What are the returns that Stryker has given to Indian investors in the last 5 years?

Stryker stock has given 102.01% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?